IRVINE - Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced its manufacturing facility in France has reached the milestone of producing and shipping 100 million syringes of JUVEDERM products globally.

Since its launch in 2000, the JUVEDERM Collection of Fillers has grown to where its products are now available in more than 110 territories worldwide and it remains the world's number one chosen dermal filler collection. 2,3 This remarkable achievement is a milestone years in the making, and further demonstrates the JUVEDERM Collection of Fillers' dedication to patients and providers globally.

'This is more than just a number. 100 million JUVEDERM syringes is a great source of pride for everyone at Allergan Aesthetics who helped make this happen,' said Carrie Strom, President, Global Allergan Aesthetics and Senior Vice President, AbbVie. 'It represents the millions of patients who've benefitted from our innovation and robust product offerings. We couldn't have done this without the years of support from all our healthcare professionals who continue to believe in and trust our products. We look forward to forging ahead as a brand, setting new goals, and continuing our legacy as the international category leader.'

The global success of JUVEDERM is in large part due to its wide range of minimally invasive treatment options specifically designed for different areas of the face. The JUVEDERM Collection of Fillers offers products that provide results that are long-lasting and natural-looking for popular treatment areas, including the lips, cheeks, and chin. 4-10 The JUVEDERM Collection of Fillers' VYCROSS technology is the number one chosen dermal filler technology worldwide. The safety and efficacy of the JUVEDERM Collection of Fillers has been demonstrated in more than 330 clinical studies. 11

'I am thrilled to celebrate this momentous occasion alongside the JUVEDERM Collection of Fillers. I trust the brand in my practice and have successfully offered it for more than 15 years,' said Dr. David Shafer, board certified plastic surgeon. 'Sixteen years of clinical studies and safety data, the widest range of filler options, and their rigorous testing protocols to ensure patient safety are just some of the reasons why I offer JUVEDERM products to my patients. I look forward to the continued innovation from the JUVEDERM Collection of Fillers and the rest of the Allergan Aesthetics portfolio for many years to come.'

In the U.S., the JUVEDERM Collection of Fillers boasts the top chosen fillers for cheeks (JUVEDERM VOLUMA XC), lower face wrinkles and folds (JUVEDERM Ultra Plus XC and JUVEDERM VOLLURE XC), lips (JUVEDERM Ultra XC and JUVEDERM VOLBELLA XC), and perioral lines (JUVEDERM VOLBELLA XC),2 all top areas of concern among patients and all areas Allergan Aesthetics offers robust training for. The company is dedicated to training aesthetic specialists on the use of all its products and their approved indications.

'I've had the honor of serving as an Allergan Medical Institute (AMI) trainer for more than six years. The training Allergan Aesthetics provides focuses on facial anatomy, considerations for safe injection, appropriate patient selection, and aseptic technique,' said Shawna Chrisman, NP. 'I work closely with aesthetic specialists across the country to help them use the JUVEDERM Collection of Fillers to achieve their patients' aesthetic goals and am truly honored to be a part of this brand's rich history and bright future.'

The JUVEDERM Collection of Fillers currently offers five specially formulated, modified hyaluronic acid (HA) fillers to address patients' varying facial treatment needs: JUVEDERM VOLUMA XC, JUVEDERM VOLBELLA XC, JUVEDERM VOLLURE XC, JUVEDERM Ultra Plus XC, JUVEDERM Ultra XC. The latest product approved by the FDA, JUVEDERM VOLUX XC for improvement of jawline definition, will be available nationwide in early 2023. 4-10 Patients who are interested in HA fillers should schedule a consultation with their aesthetic specialist to see if they're a candidate and discuss a treatment plan customized to their desired outcome.

About Allergan Aesthetics

At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. Our goal is to consistently provide our customers with innovation, education, exceptional service, and a commitment to excellence, all with a personal touch.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.

Contact:

Liz Shea

Tel: (847) 935-2211

Email: Liz.Shea@AbbVie.com

(C) 2022 Electronic News Publishing, source ENP Newswire